Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of OSP:rTTHc Cholera Conjugate Vaccine in Adults and Children
NCT07509047Phase 2Recruiting
- Sponsor
- International Vaccine Institute
- Start
- Jan 2026
- Primary completion
- Mar 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Cholera conjugate vaccine in cholera, sponsored by International Vaccine Institute. Started Jan 2026; status: recruiting.
02
Drugs
Cholera conjugate vaccine
03
Conditions
cholera
Beyond the preview
Go deeper on NCT07509047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07509047.